Correlation Between Cumberland Pharmaceuticals and CureVac NV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cumberland Pharmaceuticals and CureVac NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cumberland Pharmaceuticals and CureVac NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cumberland Pharmaceuticals and CureVac NV, you can compare the effects of market volatilities on Cumberland Pharmaceuticals and CureVac NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cumberland Pharmaceuticals with a short position of CureVac NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cumberland Pharmaceuticals and CureVac NV.

Diversification Opportunities for Cumberland Pharmaceuticals and CureVac NV

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Cumberland and CureVac is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Cumberland Pharmaceuticals and CureVac NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CureVac NV and Cumberland Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cumberland Pharmaceuticals are associated (or correlated) with CureVac NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CureVac NV has no effect on the direction of Cumberland Pharmaceuticals i.e., Cumberland Pharmaceuticals and CureVac NV go up and down completely randomly.

Pair Corralation between Cumberland Pharmaceuticals and CureVac NV

Given the investment horizon of 90 days Cumberland Pharmaceuticals is expected to generate 1.2 times more return on investment than CureVac NV. However, Cumberland Pharmaceuticals is 1.2 times more volatile than CureVac NV. It trades about 0.03 of its potential returns per unit of risk. CureVac NV is currently generating about -0.02 per unit of risk. If you would invest  135.00  in Cumberland Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of  5.00  from holding Cumberland Pharmaceuticals or generate 3.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cumberland Pharmaceuticals  vs.  CureVac NV

 Performance 
       Timeline  
Cumberland Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cumberland Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, Cumberland Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.
CureVac NV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CureVac NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, CureVac NV is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Cumberland Pharmaceuticals and CureVac NV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cumberland Pharmaceuticals and CureVac NV

The main advantage of trading using opposite Cumberland Pharmaceuticals and CureVac NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cumberland Pharmaceuticals position performs unexpectedly, CureVac NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will offset losses from the drop in CureVac NV's long position.
The idea behind Cumberland Pharmaceuticals and CureVac NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance